ValiRx - VAL201 Clinical Trial Update
VAL
Wed, 30 Sep 2020, 09:00 BST
ValiRx accelerates the development of treatments in cancer and women’s health to improve patient lives. We provide the scientific, financial and commercial framework to enable the rapid translation of innovative science into clinical development.
Industry: Health Care
Contact: +44 (0)2476 796496
Barling Way
https://www.valirx.com/
Dr Suzy Dilly, Chief Executive Officer provides an update on the headline results from the recently completed Phase 1/2 clinical trial of its lead asset VAL201, for the treatment of advanced prostate cancer, held at University College Hospital, London.
